Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Outcome of mood stabilizer discontinuation in bipolar disorder after 5 years of euthymia
P S V N Sharma1, Sreejayan Kongasseri, Samir Kumar Praharaj
1From the Department of Psychiatry, Kasturba Medical College, Manipal, Karnataka, India.
Objective:
The objective was to study the outcome of mood stabilizer discontinuation on recurrence in patients with bipolar disorder after at least 5 years of euthymia.
Methods:
Twenty-three patients diagnosed with bipolar affective disorder according to the International Classification of Diseases, 10th Revision Diagnostic Criteria for Research, receiving mood stabilizer prophylaxis for at least 5 years, had undergone planned discontinuation, and the rates and time to recurrence were studied.
Results:
Twenty (87%) of 23 patients had recurrence, and all of the episodes were manic. Kaplan-Meier survival analysis showed median time to recurrence following discontinuation of mood stabilizer prophylaxis was 10 months (SE, 6.06 months; 95% confidence interval, 0 to 21.89 months).
Conclusion:
Four fifths of our patients had recurrence following discontinuation of mood stabilizer prophylaxis within 10 months.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Electroconvulsive Therapy
Psychosis: Goals of Pharmacotherapy
Depressive Disorders: MDD and Dysthymia
Long-term Depression
Calcium Ion Concentration Mechanism
If over...

